Biophysical characterization of the interaction of bovine seminal plasma protein PDC-109 with phospholipid vesicles.
PDC-109 is the major protein of bovine seminal plasma. It binds to the bovine sperm surface at ejaculation and modulates sperm capacitation. PDC-109 displays phosphorylcholine- and heparin-binding activities which are thought to account for its sperm surface coating and glycosaminoglycan-induced sperm capacitating activities, respectively. We have characterized the interaction of isolated PDC-109 with membranes of phospholipid vesicles using a biophysical approach. Our results show that PDC-109 interacts not only with the solvent-exposed phosphorylcholine head group but also with the hydrophobic core of liposomes. Binding of PDC-109 to membranes is a very rapid, biphasic process with half times of less than one second. Maximal binding of PDC-109 to small unilamellar vesicles was achieved with a stoichiometric ratio of 10-11 phosphatidylcholine molecules/PDC-109 molecule. Incorporation of phosphatidylethanolamine or phosphatidylserine into phosphatidylcholine vesicles reduced the binding of PDC-109, suggesting that both the density of phosphorylcholine groups and the surface charge determine the interaction of the seminal plasma protein with the surface of the membrane. Electron spin resonance measurements showed that binding of PDC-109 to phosphatidylcholine vesicles caused a rigidification of the membrane. The relevance of the data for describing the role of PDC-109 in the modulation of sperm capacitation is discussed.
Müller
P
P
Humboldt-Universität zu Berlin, Mathematisch-Naturwissenschaftliche Fakultät I, Germany.
Erlemann
K R
KR
Müller
K
K
Calvete
J J
JJ
Töpfer-Petersen
E
E
Marienfeld
K
K
Herrmann
A
A
D000818:Animals; D055592:Biophysical Phenomena; D001703:Biophysics; D002417:Cattle; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D004347:Drug Interactions; D004578:Electron Spin Resonance Spectroscopy; D007700:Kinetics; D008081:Liposomes / Q000737:chemistry* / Q000378:metabolism*; D008297:Male; D008560:Membrane Fluidity / Q000187:drug effects; D010743:Phospholipids / Q000737:chemistry* / Q000378:metabolism*; D029584:Prostatic Secretory Proteins; D011506:Proteins / Q000737:chemistry* / Q000378:metabolism*; D029589:Seminal Plasma Proteins; D012995:Solubility; D013050:Spectrometry, Fluorescence; D013113:Spin Labels; D014867:Water / Q000737:chemistry
D008081:Liposomes; D010743:Phospholipids; D029584:Prostatic Secretory Proteins; D011506:Proteins; D029589:Seminal Plasma Proteins; D013113:Spin Labels; C043076:beta-microseminoprotein; D014867:Water